Active

Contract Opportunity

The Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Office of Resource Management (ORM), Strategic National Stockpile (SNS) intend to use other than full and open competition to award a sole source contract to Meridian Medical Technologies, LLC to provide DuoDote Single Dose Autoinjector due to unexpected FDA testing failures of Antidote Nerve Agent Autoinjector (ATNAA) which has caused and inventory shortage and denial to State and local agencies that depend on SNS medical countermeasures used for medical and national emergencies.

This notice of intent to award a sole source contract will be posted for five (5) calendar days to verify that no other sources can meet this requirement given only one responsible source and no other supplies or services will satisfy the Government requirements. This five (5) calendar day notice shall expire on September 18, 2023 at 12:00 PM Eastern Standard Time.

If no credible responses to the intent to sole source are received, the Government intends negotiate a fixed price contract to Meridian Medical Technologies, LLC. The proposed contract action will

support supplies and services for which the Government intends to solicit and negotiate with only one source under the authority of the Federal Acquisition Regulation (FAR) 6.302-1 entitled Only one responsible source and no other supplies or services will satisfy agency requirements, 41 U.S.C. 3304(a)(3). This notice of intent is NOT a request for competitive proposals.

Interested parties may identify their interest and capability to respond to this requirement by submitting in writing their name, address, telephone number, email, and a statement regarding capability to provide the specified requirement.

Responses shall be limited to ten (10) pages or less, including all attachments. Interested parties will be considered only if they respond to this notice with clear and convincing evidence that competition would be advantageous to the Government, would not be cost or time prohibitive. All capability statements, proposals, or quotes received prior to September 18, 2023, at 12:00 PM ET will be considered by the Government. The Government will not be responsible for any costs incurred by responding to this notice. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

Anticipated Award Date and Period of Performance:

The Government anticipates an award date in FY2023. The estimated period of performance is 12 months from date of award.

Delivery Schedule:

The delivery schedule will be established during contract negotiations.

Contract type:

The Government proposes the award of firm-fixed price contract for the procurement of DuoDote Single Dose Autoinjectors.

Background:

The mission of the Strategic National Stockpile (SNS), of the United States (U.S.) Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR), is to ensure the availability and rapid deployment of life-saving pharmaceuticals, antidotes, other medical supplies, and equipment necessary to counter the effects of biological, chemical, radiological, natural disasters, or other emerging infectious disease agents. When state, local, tribal, and territorial public health and medical systems request federal assistance to support their response efforts, SNS ensures that the right medicines and supplies get to those who need them most during a public health emergency or pandemic event.

The Strategic National Stockpile (SNS) is a national repository of pharmaceuticals, vaccines, medical supplies, and medical equipment stored in strategic locations around the nation. These assets are designed to supplement state and local public health departments in the event of a large-scale public health emergency that causes local supplies to run out. Pharmaceuticals and Medical Supplies are strategically stored in a network of warehouses across the country for rapid deployment to protect the U.S. population against 21st century health security threats, such as anthrax, botulism, smallpox, plague, tularemia, and viral hemorrhagic fevers, as well as emerging infectious diseases, pandemic influenza, natural disasters, and other chemical, biological, radiological, and nuclear incidents.

The SNS has a need to procure a variety of FDA approved pharmaceuticals to maintain minimum stockpiling capabilities for responding to public health events. The Contractor, as an independent organization and not as an agent of the Government, shall procure and furnish all labor, materials, supplies, facilities, equipment, transportation and travel necessary to deliver the acceptable pharmaceuticals. The contractor shall provide brand name or equal product for the pharmaceutical on or before 9/30/2023.

Attachments/Links

Download All Attachments/Links